| Before UHC (1998–2002) N = 355 | After UHC (2003–2012) N = 822 | p-value | Total N = 1177 |
---|---|---|---|---|
Characteristics | ||||
 Median (IQR) age at diagnosis (year) | 52 (42–61) | 56 (48–68) | < 0.001a | 55 (46–66) |
 Age group, n(%) |  |  | < 0.001b |  |
  15–29 | 8 (2) | 5 (1) |  | 13(1) |
  30–59 | 239 (67) | 474 (58) |  | 713 (61) |
   ≥ 60 | 108 (30) | 343 (42) |  | 451 (38) |
 Median (IQR) age at death (year) | 54 (45–65) | 60 (51–71) | < 0.001a | 58 (49–69) |
 Age group, n(%) |  |  | < 0.001b |  |
  15–29 | 5 (1) | 3 (< 1) |  | 8 (1) |
  30–59 | 218 (62) | 402 (49) |  | 620 (53) |
   ≥ 60 | 132(37) | 417 (51) |  | 549 (46) |
 Extent of disease,n(%) |  |  | 0.278b |  |
  Localized | 58 (16) | 154 (19) |  | 212 (18) |
  Regional | 254 (72) | 558 (68) |  | 812 (69) |
  Metastatic | 28 (8) | 85 (10) |  | 113 (10) |
  Unknown | 15 (4) | 25 (3) |  | 40 (3) |
 Area of residence, n(%) |  |  | < 0.001b |  |
  Urban | 134 (38) | 437 (53) |  | 571 (49) |
  Rural | 98 (28) | 327 (40) |  | 425 (36) |
  Unknown | 123 (35) | 58 (7) |  | 181 (15) |